Peripheral nerve disease in SARS: Report of a case
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Severe acute respiratory syndrome (SARS), an infection caused by a novel coronavirus, 1 is a life-threatening respiratory disease, which has broken out worldwide. Although the clinical features in the epidemic areas have been reported in detail, 2 no neurologic manifestations have been mentioned. We report a SARS patient who developed acute paresthesia and weakness in her lower limbs during the period of mechanical ventilator support.
Case report. The husband of a previously well 51-year-old woman returned to Taiwan in February 2003 from a 16-day stay in Guangdong, China, and began to experience fever (Ͼ38°C), cough, and myalgia on February 25. Progressive respiratory dis- The H reflexes from bilateral tibial nerves were absent in the first and follow-up nerve conduction studies (NCS).
RT ϭ right; LT ϭ left; Nor. ϭ normal limit in our electrodiagnostic laboratory; Abs. ϭ absent; m ϭ motor; s ϭ sensory.
tress was noted, and chest x-ray (CXR) showed bilateral pneumonia. He was intubated on March 10. Based on the traveling history, clinical manifestations, and CXR findings, he was diagnosed with probable SARS. 3 His wife then developed high fever (39.1°C), sore throat, watery diarrhea, and cough with dyspnea. Her CXR taken on March 14 showed increased infiltration in the right lower lobe. Laboratory studies showed raised glutamicpyruvic transaminase and lactate dehydrogenase levels with leukopenia (white blood cell count ϭ 1,980/mm 3 ). A tentative diagnosis of probable SARS was made. No weakness or sensory disturbance was noted at that time. Her respiratory status deteriorated gradually, and she was intubated on March 17. Broadspectrum antibiotics and inhalation of ribavirin were given as infection treatment. Examinations for respiratory syncytial virus, parainfluenza virus, influenza virus, adenovirus, enterovirus, Legionellae, and mycoplasma infections all yielded negative results. Widal and Weil-Felix tests were normal. Results of bone marrow biopsy suggested infection-associated hemophagocytic syndrome. IV immunoglobulin (1 g/kg/day for 2 days) and methylprednisolone (40 mg IV q8 hours) were given for possible virus-related immune reactions. The patient's condition improved, and she was extubated on March 26. However, after extubation, she had severe weakness and numbness in both legs. Instead of increasing, the weakness and numbness started to disappear.
A detailed neurologic workup 10 days after extubation showed that her mental state was clear and cranial nerves were intact. Muscle power examination revealed relatively symmetric weakness in the lower limbs: 4/5 in hip flexion and extension, 3 to 4/5 in knee extension, 2/5 in knee flexion, 1/5 in ankle dorsiflexion, and 2/5 in ankle plantar flexion. Only mild weakness was noted in the hands. Ankle jerks were absent, but other tendon reflexes were preserved. The plantar responses were flexor. Sensory examination revealed a stocking distribution of paresthesia with impairment to all sensory modalities below the knee. There were no cerebellar signs or sphincter problems.
Nerve conduction study (NCS) was then performed (table) . Decreased amplitude of compound muscle action potentials (CMAP) was noted in both peroneal nerves. The F-wave latencies in the legs were absent or mildly prolonged or near the upper normal limits. H reflex could not be elicited bilaterally. Other NCS findings including the distal motor latencies and motor nerve conduction velocities were normal. No temporal dispersion or conduction block was found. Electromyographic (EMG) studies in the right anterior tibialis muscle showed active fibrillation potentials, positive waves, and neurogenic polyphasic waves. Findings of somatosensory evoked potentials were normal. Results of lumbosacral x-ray and MRI excluded local lesions in the nerve roots. Because her neurologic deficits had much improved, the patient refused CSF study.
A follow-up neurologic examination 2 months later showed only minimal weakness in knee flexion and mild weakness (4/5) in foot dorsiflexion and plantar flexion. The sensations were normal except for mild numbness in her right toes. The follow-up NCS revealed improvement (see the table) .
Discussion. The diagnosis of probable SARS in this patient was based on the definition established by the World Health Organization, 3 including history of exposure (her husband), typical clinical manifestations and laboratory findings, and detailed workup to exclude possibilities of common bacterial or viral infections. We first diagnosed polyradiculoneuropathy in our SARS patient. Critical illness polyneuropathy (CIP) (an acute neuropathy that develops during severe illness and remits after the critical illness is under control) should first be considered. Our patient had clinical and electrophysiologic findings consistent with CIP (reduced CMAP amplitude, abnormal spontaneous activities in EMG, abnormal F responses and H reflex). 4 We did not diagnose Guillain-Barré syndrome (GBS) because of the discrepancy between neurologic deficits present in the lower limbs and absent in the upper limbs (not typical for GBS), no evidence of demyelination in the NCS (against acute inflammatory demyelinating polyradiculoneuropathy), and the rapid improvement after extubation (unusual for acute motor-sensory axonal neuropathy). We reviewed all the drugs used in the critical period and excluded the possibility of toxic neuropathy.
The pathogenesis of her polyradiculoneuropathy is unknown. Sepsis, that is, the systemic inflammatory response syndrome, has been proposed to play a role in the nerve damage of CIP.
5 SARS could cause immune dysfunction 6, 7 with release of various proinflammatory immune mediators that might damage not only the lungs but also the nerves. The recommendation of steroid therapy 7 also supports an important role of immunopathologic damages in SARS. Moreover, nerve roots and terminals in which blood-nerve barriers are congenitally incomplete might be more vulnerable to such damage. Whether the coronavirus can directly damage peripheral nerves is unknown and needs further investigation.
